Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments
Authors
Keywords
Cancer, Stathmin, Drug target, Anticancer therapy, Molecular targeted therapy
Journal
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-27
DOI
10.1186/s12967-016-1000-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells
- (2016) Michelle J. Nyhan et al. BMC CANCER
- Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells
- (2016) Xuechi Lin et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Novel indolyl-chalcones target stathmin to induce cancer cell death
- (2016) Barbara Wegiel et al. CELL CYCLE
- RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis
- (2016) G N Alesi et al. ONCOGENE
- Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo
- (2016) Zhi-jian Meng et al. ONCOLOGY RESEARCH
- Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma
- (2016) Suely Kazue Nagahashi Marie et al. Proteome Science
- Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma
- (2016) Xiaoying He et al. TUMOR BIOLOGY
- ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells
- (2015) João Agostinho Machado-Neto et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel
- (2015) W Feng et al. CANCER GENE THERAPY
- Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel
- (2015) H.W. Zhu et al. GENETICS AND MOLECULAR RESEARCH
- Stathmin over-expression correlates with poor prognosis in patients with endometrial cancer
- (2015) H.D. Reyes et al. GYNECOLOGIC ONCOLOGY
- A Time to Kill: Targeting Apoptosis in Cancer
- (2015) Jean Koff et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma
- (2015) K. A. Birnie et al. MOLECULAR CANCER RESEARCH
- Deceivingly dynamic: Learning-dependent changes in stathmin and microtubules
- (2015) Shusaku Uchida et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma
- (2015) Shuai Wang et al. TUMOR BIOLOGY
- Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer
- (2015) Ruifang Sun et al. TUMOR BIOLOGY
- siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines
- (2014) Yuwen Song et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Stathmin is a Marker of Progression and Poor Prognosis in Esophageal Carcinoma
- (2014) Feng Wang et al. Asian Pacific Journal of Cancer Prevention
- The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
- (2014) T Hemdan et al. BRITISH JOURNAL OF CANCER
- Op18/Stathmin Is Involved in the Resistance of Taxol Among Different Epithelial Carcinoma Cell Lines
- (2014) Xuechi Lin et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma
- (2014) Akira Watanabe et al. CANCER SCIENCE
- Genetic characterization of p27kip1and stathmin in controlling cell proliferation in vivo
- (2014) Stefania Berton et al. CELL CYCLE
- Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells
- (2014) Xi Chen et al. CELLULAR SIGNALLING
- Stathmin, Interacting with Nf-κB, Promotes Tumor Growth and Predicts Poor Prognosis of Pancreatic Cancer
- (2014) Y. Lu et al. CURRENT MOLECULAR MEDICINE
- Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition
- (2014) Yu Lu et al. Hepatobiliary & Pancreatic Diseases International
- FOXM1 mediates resistance to docetaxel in gastric cancerviaup-regulating Stathmin
- (2014) Xiaoxiao Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse
- (2014) Javed Akhtar et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients
- (2014) Ei Ahn et al. Journal of Translational Medicine
- Merkel Cell Polyomavirus Small T Antigen Mediates Microtubule Destabilization To Promote Cell Motility and Migration
- (2014) Laura M. Knight et al. JOURNAL OF VIROLOGY
- Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer
- (2014) Wei Nie et al. LABORATORY INVESTIGATION
- Unbiased Proteomic and Transcript Analyses Reveal that Stathmin-1 Silencing Inhibits Colorectal Cancer Metastasis and Sensitizes to 5-Fluorouracil Treatment
- (2014) W. Wu et al. MOLECULAR CANCER RESEARCH
- Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
- (2014) Henrica M. J. Werner et al. PLoS One
- Stathmin Mediates Hepatocyte Resistance to Death from Oxidative Stress by down Regulating JNK
- (2014) Enpeng Zhao et al. PLoS One
- Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling
- (2014) Simon Schimmack et al. TUMOR BIOLOGY
- Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection
- (2014) Kotaro Kiga et al. Nature Communications
- Overcoming Paclitaxel Resistance in Lung Cancer Cells Via Dual Inhibition of Stathmin and Bcl-2
- (2013) Zheng-Xiang Han et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer
- (2013) C Miceli et al. CANCER GENE THERAPY
- High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- Platinum-Based Agents for Individualized Cancer Treatment
- (2013) X. Chen et al. CURRENT MOLECULAR MEDICINE
- Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
- (2013) Maura Sonego et al. EMBO Molecular Medicine
- Stathmin overexpression identifies high risk for lymphatic metastatic recurrence inpN0esophageal squamous cell carcinoma patients
- (2013) Javed Akhtar et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MicroRNAs Transfer from Human Macrophages to Hepato-Carcinoma Cells and Inhibit Proliferation
- (2013) A. Aucher et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression
- (2013) Yuwen Song et al. JOURNAL OF NEURO-ONCOLOGY
- Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo
- (2013) Javed Akhtar et al. Journal of Translational Medicine
- Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells
- (2013) João Agostinho Machado-Neto et al. LEUKEMIA RESEARCH
- Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1
- (2013) Victoria C. Silva et al. MOLECULAR BIOLOGY OF THE CELL
- RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model
- (2013) F L Byrne et al. ONCOGENE
- Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer
- (2013) Bin Ke et al. TUMOR BIOLOGY
- Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma
- (2013) Han-Ping Hsu et al. TUMOR BIOLOGY
- A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells
- (2013) Yong Wu et al. CELLULAR ONCOLOGY
- Stathmin-1 Expression as a Complement to p16 Helps Identify High-grade Cervical Intraepithelial Neoplasia With Increased Specificity
- (2012) Brooke E. Howitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma
- (2012) Yi-Ling Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Effects of Monoclonal Antibodies against Human Stathmin Combined with Paclitaxel on Proliferation of the QG-56 Human Lung Carcinoma Cell Line
- (2012) Shao-Fei Yuan et al. Asian Pacific Journal of Cancer Prevention
- Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression
- (2012) Serban San-Marina et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer
- (2012) Maria T. Baquero et al. CANCER
- Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells
- (2012) M Long et al. CANCER GENE THERAPY
- Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle
- (2012) Xuechi Lin et al. CANCER SCIENCE
- Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder
- (2012) Divya Bhagirath et al. CLINICA CHIMICA ACTA
- Stathmin 1 is a potential novel oncogene in melanoma
- (2012) J Chen et al. ONCOGENE
- Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer
- (2012) Wei Kang et al. PLoS One
- MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1
- (2012) Rui Wang et al. PLoS One
- EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
- (2011) RONG Biao-xue et al. CURRENT CANCER DRUG TARGETS
- In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein
- (2011) Anagha P. Phadke et al. DNA AND CELL BIOLOGY
- Stathmin: a protein with many tasks. New biomarker and potential target in cancer
- (2011) Barbara Belletti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas
- (2011) Alison M. Karst et al. GYNECOLOGIC ONCOLOGY
- LRRC4 inhibits the proliferation of human glioma cells by modulating the expression of STMN1 and microtubule polymerization
- (2011) Rong Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Proteomic Analysis of Colorectal Cancer Metastasis: Stathmin-1 Revealed as a Player in Cancer Cell Migration and Prognostic Marker
- (2011) Hwee Tong Tan et al. JOURNAL OF PROTEOME RESEARCH
- Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma
- (2011) Feng Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients With Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy
- (2011) Matthew S. Wosnitzer et al. JOURNAL OF UROLOGY
- Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules
- (2011) N. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DrosophilaStathmins Bind Tubulin Heterodimers with High and Variable Stoichiometries
- (2010) Sylvie Lachkar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis
- (2010) Manimalha Balasubramani et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Membrane transport of WAVE2 and lamellipodia formation require Pak1 that mediates phosphorylation and recruitment of stathmin/Op18 to Pak1–WAVE2–kinesin complex
- (2009) Kazuhide Takahashi et al. CELLULAR SIGNALLING
- Stathmin 1: a novel therapeutic target for anticancer activity
- (2008) Shushan Rana et al. Expert Review of Anticancer Therapy
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started